Tina Ventura | Horizon Pharma Plc |
Timothy P. Walbert | Horizon Pharma Plc |
Paul W. Hoelscher | Horizon Pharma Plc |
Jeffrey W. Sherman, M.D., FACP | Horizon Pharma Plc |
David A. Happel | Horizon Pharma Plc |
Vikram Karnani | Horizon Pharma Plc |
Eric Mosbrooker | Horizon Pharma Plc |
Robert F. Carey | Horizon Pharma Plc |
Dana Flanders | Goldman Sachs & Co. LLC |
David Michael Steinberg | Jefferies LLC |
Marc Goodman | UBS Securities LLC |
Annabel Eva Samimy | Stifel, Nicolaus & Co., Inc. |
David A. Amsellem | Piper Jaffray & Co. |
Louise Chen | Cantor Fitzgerald Securities |
Gary Nachman | BMO Capital Markets (United States) |
Irina Rivkind Koffler | Mizuho Securities USA, Inc. |
Liav Abraham | Citigroup Global Markets, Inc. |
Good morning and thank you for standing by. Welcome to the Horizon Pharma Plc Third Quarter 2017 Earnings Conference Call.
As a reminder, today's conference call is being recorded. I would now like to introduce Ms. Tina Ventura, Senior Vice President of Investor Relations.